Why Momentum Stocks & ETFs Are Crushing the Market

Factor investing focuses on identifying stocks with certain characteristics, or factors, such as value, quality, momentum, size, and minimum volatility that have historically been linked to higher returns.

However, factor returns have generally proven to be highly cyclical, and timing the market is never easy. One year, low volatility might be in favor, while the next year, momentum could dominate.

Over the past 10 and 15 years, only two factor indexes—quality and momentum—have outpaced the broader market.

This year, the momentum factor is a standout performer as investors continue to pour money into the hottest stocks. The Invesco S&P 500 Momentum ETF SPMO has skyrocketed almost 50%, while the iShares MSCI USA Momentum Factor ETF MTUM has gained 40%.

The momentum effect, which refers to the tendency of winning stocks to outperform losing stocks, has been documented in many academic studies, including the seminal paper by Jegadeesh and Titman (1993).

Last year, the MTUM ETF underperformed the broader market, as it added the highflier NVIDIA NVDA only during its May rebalancing, missing the stock’s meteoric rise earlier in the year. Additionally, the ETF was tilted toward the underperforming healthcare sector.

The SPMO ETF is top-heavy, with its top five holdings—Amazon AMZN, NVIDIA, Meta Platforms META, Berkshire Hathaway (BRK.B), and Eli Lilly LLY—comprising 37% of the portfolio. Since its inception in October 2015, the product has surged over 331%, significantly outperforming the S&P 500’s SPY 250% gain and MTUM’s 235% rise during the same period.

To learn more, please watch short video above.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research